Alternative Anti-inflammatory Treatments When NSAIDs Are Contraindicated

Introduction to Alternative Treatments

The American Heart Association recommends using acetaminophen as the first-line agent for inflammation when NSAIDs are contraindicated, followed by nonacetylated salicylates if additional anti-inflammatory effect is needed 1, 2

Acetaminophen provides comparable pain relief to NSAIDs in many conditions, though with less anti-inflammatory effect, and should be started with 650 mg every 4-6 hours (maximum 4g/day) 1, 2
Monitoring for hepatic toxicity is essential when using acetaminophen, especially with chronic use or in patients with liver disease 3
Nonacetylated salicylates, such as choline magnesium salicylate and salsalate, can be considered when acetaminophen provides insufficient anti-inflammatory effect, and do not inhibit platelet aggregation, making them safer in patients with bleeding risk 4, 1

Selective COX-2 inhibitors may be considered in patients where NSAIDs are contraindicated due to GI risk but not cardiovascular risk, but should be used with caution as they increase cardiovascular risk, especially in patients with established cardiovascular disease 1, 5
Low-dose narcotics/opioids can be used for short-term management when other options fail, but have equal effectiveness for pain relief compared to NSAIDs and lead to significantly more side effects 1, 6

The American College of Cardiology notes that NSAIDs with increasing COX-2 selectivity increase cardiovascular risk, with hazard ratios ranging from 1.29 to 2.80 depending on the specific agent, and this risk appears amplified in patients with established cardiovascular disease 1, 5
All NSAIDs should be used with caution in patients with renal impairment, and monitoring of BUN and creatinine is essential, with discontinuation if values double or if hypertension develops 4
The American College of Gastroenterology recommends considering gastroprotective agents (PPIs) when using NSAIDs in high-risk patients, such as those with age >60 years, history of peptic ulcer disease, and concomitant steroid use 8, 2